Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Sun Pharma Advanced Research Company Limited engages in the research and development of pharmaceutical products in India and internationally. It develops Sezaby, a benzyl alcohol and propylene glycol free formulation of phenobarbital sodium injection for the treatment of neonatal seizures; SPARC-121, a novel topical agent for the treatment of Alopecia Areata; and SPARC-122, an anti-MUC1 ADC for treatment of multiple cancer indications. The company is also involved in the development of PDP-716 for treatment of open-angle glaucoma. Sun Pharma Advanced Research Company Limited was incorporated in 2006 and is based in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 6,475 Cr
P/E 4.06
Div Yield 0.00 %
Book Value โน41.30
52w High โน289.00
52w Low โน108.00
Face Value โน1.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
40.00
1,853.00
8.00
8.00
10.00
27.00
15.00
13.00
17.00
17.00
14.00
21.00
24.00
Expenses
74.00
80.00
65.00
74.00
62.00
81.00
89.00
117.00
112.00
124.00
116.00
113.00
126.00
Operating Profit
-34.00
1,773.00
-57.00
-66.00
-52.00
-54.00
-74.00
-104.00
-95.00
-108.00
-103.00
-91.00
-102.00
OPM %
-86.00
96.00
-673.00
-838.00
-543.00
-198.00
-499.00
-808.00
-566.00
-649.00
-740.00
-432.00
-427.00
Other Income
24.00
2.00
-12.00
0.00
9.00
0.00
0.00
0.00
2.00
4.00
6.00
8.00
10.00
Depreciation
2.00
2.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
Interest
8.00
12.00
9.00
8.00
6.00
5.00
3.00
1.00
1.00
1.00
0.00
0.00
0.00
Profit before tax
-21.00
1,761.00
-81.00
-76.00
-52.00
-61.00
-80.00
-108.00
-97.00
-107.00
-100.00
-86.00
-95.00
Tax %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-21.00
1,761.00
-81.00
-76.00
-52.00
-61.00
-80.00
-108.00
-97.00
-107.00
-100.00
-86.00
-95.00
EPS in Rs
-0.65
54.26
-2.48
-2.34
-1.60
-1.88
-2.46
-3.32
-2.98
-3.29
-3.07
-2.66
-2.94
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
1,879.00 72.00 76.00 239.00 137.00 253.00 77.00 183.00 78.00 181.00 161.00 156.00
Expenses
281.00 399.00 479.00 453.00 324.00 388.00 387.00 334.00 321.00 304.00 224.00 191.00
Operating Profit
1,598.00 -327.00 -404.00 -214.00 -187.00 -135.00 -310.00 -151.00 -243.00 -123.00 -63.00 -35.00
OPM %
85.00 -456.00 -534.00 -90.00 -136.00 -53.00 -404.00 -83.00 -310.00 -68.00 -39.00 -23.00
Other Income
-2.00 2.00 29.00 11.00 7.00 5.00 10.00 14.00 54.00 14.00 3.00 3.00
Interest
34.00 9.00 2.00 8.00 13.00 11.00 3.00 0.00 0.00 2.00 2.00 0.00
Depreciation
10.00 11.00 12.00 12.00 10.00 11.00 9.00 8.00 8.00 8.00 8.00 7.00
Profit before tax
1,552.00 -345.00 -388.00 -223.00 -203.00 -151.00 -312.00 -145.00 -197.00 -119.00 -70.00 -40.00
Tax %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Profit
1,552.00 -345.00 -388.00 -223.00 -203.00 -151.00 -312.00 -145.00 -197.00 -119.00 -70.00 -40.00
EPS in Rs
47.83 -10.64 -11.96 -6.86 -7.48 -5.77 -11.92 -5.55 -7.85 -4.82 -2.83 -1.60
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
32.00 32.00 32.00 32.00 27.00 26.00 26.00 26.00 25.00 25.00 24.00 24.00
Reserves
1,301.00 -253.00 92.00 480.00 4.00 -194.00 -45.00 270.00 160.00 133.00 8.00 76.00
Borrowings
559.00 265.00 56.00 16.00 79.00 236.00 67.00 2.00 2.00 3.00 56.00 4.00
Other Liabilities
275.00 284.00 305.00 302.00 170.00 162.00 224.00 101.00 122.00 111.00 75.00 39.00
Total Liabilities
2,168.00 329.00 486.00 830.00 280.00 230.00 273.00 398.00 309.00 273.00 163.00 143.00
Fixed Assets
85.00 95.00 103.00 106.00 92.00 91.00 104.00 58.00 52.00 69.00 70.00 67.00
CWIP
72.00 54.00 44.00 27.00 26.00 5.00 32.00 24.00 3.00 1.00 1.00 0.00
Investments
0.00 0.00 2.00 291.00 12.00 6.00 8.00 211.00 108.00 10.00 0.00 0.00
Other Assets
2,011.00 179.00 338.00 406.00 150.00 127.00 128.00 106.00 146.00 192.00 92.00 76.00
Total Assets
2,168.00 329.00 486.00 830.00 280.00 230.00 273.00 398.00 309.00 273.00 163.00 143.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
-239.00 -362.00 -429.00 -69.00 -208.00 -152.00 -211.00 -172.00 -183.00 -128.00 -44.00 -41.00
Cash from Investing Activity
-24.00 158.00 391.00 -548.00 -29.00 2.00 155.00 -102.00 -105.00 -7.00 -13.00 53.00
Cash from Financing Activity
262.00 201.00 43.00 617.00 229.00 159.00 55.00 274.00 224.00 194.00 51.00 -1.00
Net Cash Flow
-1.00 -4.00 4.00 -1.00 -8.00 9.00 0.00 0.00 -63.00 60.00 -7.00 11.00
Free Cash Flow
-262.00 -372.00 -455.00 -84.00 -233.00 -153.00 -264.00 -184.00 -200.00 -136.00 -56.00 -49.00
CFO/OP %
-17.00 114.00 105.00 35.00 114.00 111.00 65.00 111.00 71.00 88.00 48.00 110.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
2.00 82.00 75.00 50.00 74.00 25.00 76.00 20.00 82.00 78.00 21.00 47.00
Inventory Days
โ โ โ โ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
2.00 82.00 75.00 50.00 74.00 25.00 76.00 20.00 82.00 78.00 21.00 47.00
Working Capital Days
214.00 -1,778.00 -746.00 -193.00 -301.00 -268.00 -842.00 -98.00 -232.00 -60.00 -161.00 20.00
ROCE %
165.00 -298.00 -109.00 -67.00 -218.00 -242.00 -183.00 -62.00 -143.00 -94.00 -71.00 -32.00
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
65.68
65.67
65.67
65.67
65.67
65.68
65.68
65.68
65.68
65.68
65.68
65.68
FIIs
3.90
2.04
2.04
1.76
1.47
1.45
2.23
2.15
2.64
3.24
3.30
3.67
DIIs
0.09
0.88
0.78
1.05
0.97
1.13
0.64
0.21
0.17
0.67
0.67
0.65
Public
30.34
31.41
31.51
31.52
31.88
31.76
31.47
31.96
31.51
30.41
30.36
29.99
No. of Shareholders
141,957
140,625
144,810
136,997
140,724
142,864
131,034
128,205
125,184
102,743
103,990
101,433
Corporate Actions
20 records
Back to all stocks